Arbutus Biopharma Corp
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $169.4M | $109.3M |
| FY2022 | $0 | $136.9M | $30.8M |
| FY2023 | $0 | $106.0M | $26.3M |
| FY2024 | $0 | $97.4M | $36.3M |
| FY2025 | $0 | $76.6M | $18.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $169.4M | $109.3M |
| FY2022 | $0 | $136.9M | $30.8M |
| FY2023 | $0 | $106.0M | $26.3M |
| FY2024 | $0 | $97.4M | $36.3M |
| FY2025 | $0 | $76.6M | $18.0M |